Accelerated Partial Breast Irradiation for HER2-Positive Early-Stage Breast Cancer.
Int J Radiat Oncol Biol Phys.
2024 Feb 1;118(2):468-473. doi: 10.1016/j.ijrobp.2023.08.062. Epub 2023 Oct 2. PubMed PMID:
37791937.
Accelerated Partial Breast Irradiation: Association of Dosimetric Parameters With Patient-Reported Outcomes.
Adv Radiat Oncol.
2023 Nov-Dec;8(6):101263. doi: 10.1016/j.adro.2023.101263. eCollection 2023 Nov-Dec. PubMed PMID:
37305071; PubMed Central PMCID:
PMC10248091.
Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ.
Adv Radiat Oncol.
2023 Sep-Oct;8(5):101254. doi: 10.1016/j.adro.2023.101254. eCollection 2023 Sep-Oct. PubMed PMID:
37250283; PubMed Central PMCID:
PMC10220256.
Non-cell-autonomous cancer progression from chromosomal instability.
Nature.
2023 Aug;620(7976):1080-1088. doi: 10.1038/s41586-023-06464-z. Epub 2023 Aug 23. PubMed PMID:
37612508; PubMed Central PMCID:
PMC10468402.
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial.
Pract Radiat Oncol.
2023 Jul-Aug;13(4):314-320. doi: 10.1016/j.prro.2023.03.006. Epub 2023 May 1. PubMed PMID:
37140504.
Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone Versus Hormone Therapy Alone or Combined Treatment for Low-Risk ER-Positive Early Stage Breast Cancer in Women Aged 65 Years and Older.
Int J Radiat Oncol Biol Phys.
2023 Jul 1;116(3):617-626. doi: 10.1016/j.ijrobp.2022.12.028. Epub 2022 Dec 28. PubMed PMID:
36586492.
Regional nodal irradiation for breast cancer using volumetric modulated arc therapy: Echocardiographic functional outcomes.
Res Sq.
2023 Jun 8;. doi: 10.21203/rs.3.rs-2908730/v1. PubMed PMID:
37333127; PubMed Central PMCID:
PMC10274959.
Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival.
Breast Cancer Res Treat.
2023 Jun;199(2):355-361. doi: 10.1007/s10549-023-06923-1. Epub 2023 Mar 28. PubMed PMID:
36976395.
Accuracy and Efficiency of Patient Setup Using Surface Imaging versus Skin Tattoos for Accelerated Partial Breast Irradiation.
Adv Radiat Oncol.
2023 May-Jun;8(3):101183. doi: 10.1016/j.adro.2023.101183. eCollection 2023 May-Jun. PubMed PMID:
36896216; PubMed Central PMCID:
PMC9991531.
Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy.
Int J Radiat Oncol Biol Phys.
2023 Mar 1;115(3):622-628. doi: 10.1016/j.ijrobp.2022.09.065. Epub 2022 Sep 22. PubMed PMID:
36155213.
Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer.
Breast Cancer Res Treat.
2023 Feb;198(1):43-51. doi: 10.1007/s10549-022-06853-4. Epub 2023 Jan 5. PubMed PMID:
36604352.
In Regard to Vaidya et al.
Int J Radiat Oncol Biol Phys.
2023 Jan 1;115(1):255-256. doi: 10.1016/j.ijrobp.2022.10.003. PubMed PMID:
36526391.
The Effect of Surgeon Referral and a Radiation Oncologist Productivity-Based Metric on Radiation Therapy Receipt Among Elderly Women With Early Stage Breast Cancer: Analysis From a Tertiary Cancer Network.
Adv Radiat Oncol.
2023 Jan-Feb;8(1):101113. doi: 10.1016/j.adro.2022.101113. eCollection 2023 Jan-Feb. PubMed PMID:
36483067; PubMed Central PMCID:
PMC9723302.
Partial breast irradiation: An updated consensus statement from the American brachytherapy society.
Brachytherapy.
2022 Nov-Dec;21(6):726-747. doi: 10.1016/j.brachy.2022.07.004. Epub 2022 Sep 15. Review. PubMed PMID:
36117086.
A Comparison of Patient- and Clinician-Reported Acute Toxic Effects During Radiation Therapy for Primary Breast Cancer.
Int J Radiat Oncol Biol Phys.
2022 Oct 1;114(2):301-309. doi: 10.1016/j.ijrobp.2022.05.041. Epub 2022 Jun 5. PubMed PMID:
35675851; PubMed Central PMCID:
PMC10281649.
In Reply to Rabinovitch.
Pract Radiat Oncol.
2022 May-Jun;12(3):e243-e244. doi: 10.1016/j.prro.2022.02.001. PubMed PMID:
35512994.
Bilateral Regional Nodal Irradiation Using Volumetric Modulated Arc Therapy: Dosimetric Analysis and Feasibility.
Pract Radiat Oncol.
2022 May-Jun;12(3):189-194. doi: 10.1016/j.prro.2021.11.008. Epub 2022 Jan 16. PubMed PMID:
35045364; PubMed Central PMCID:
PMC9081150.
Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation.
Radiother Oncol.
2021 Dec;165:142-151. doi: 10.1016/j.radonc.2021.10.010. Epub 2021 Oct 22. PubMed PMID:
34688807; PubMed Central PMCID:
PMC9554730.
Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer.
Int J Radiat Oncol Biol Phys.
2021 Nov 15;111(4):979-991. doi: 10.1016/j.ijrobp.2021.07.1692. Epub 2021 Jul 24. PubMed PMID:
34314814; PubMed Central PMCID:
PMC8530913.
Ultra-Short Fraction Schedules as Part of De-intensification Strategies for Early-Stage Breast Cancer.
Ann Surg Oncol.
2021 Sep;28(9):5005-5014. doi: 10.1245/s10434-020-09526-y. Epub 2021 Jan 13. Review. PubMed PMID:
33442837.
Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-Analysis.
Ann Surg Oncol.
2021 Sep;28(9):4985-4994. doi: 10.1245/s10434-020-09447-w. Epub 2021 Jan 3. PubMed PMID:
33393051.
Are 5-Year Randomized Clinical Trial Results Sufficient for Implementation of Short-Course Whole Breast Radiation Therapy?.
Pract Radiat Oncol.
2021 Sep-Oct;11(5):301-304. doi: 10.1016/j.prro.2021.03.011. Review. PubMed PMID:
34479656; PubMed Central PMCID:
PMC9227962.
Cost-Effectiveness Analysis of No Adjuvant Therapy Versus Partial Breast Irradiation Alone Versus Combined Treatment for Treatment of Low-Risk DCIS: A Microsimulation.
JCO Oncol Pract.
2021 Aug;17(8):e1055-e1074. doi: 10.1200/OP.20.00992. Epub 2021 May 10. PubMed PMID:
33970684.
Salvage of locally recurrent breast cancer with repeat breast conservation using 45 Gy hyperfractionated partial breast re-irradiation.
Breast Cancer Res Treat.
2021 Jul;188(2):409-414. doi: 10.1007/s10549-021-06206-7. Epub 2021 Mar 26. PubMed PMID:
33770311.
Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer.
Sci Rep.
2021 Jun 17;11(1):12781. doi: 10.1038/s41598-021-92343-4. PubMed PMID:
34140615; PubMed Central PMCID:
PMC8211664.
Breast conservation among older patients with early-stage breast cancer: Locoregional recurrence following adjuvant radiation or hormonal therapy.
Cancer.
2021 Jun 1;127(11):1749-1757. doi: 10.1002/cncr.33422. Epub 2021 Jan 26. PubMed PMID:
33496354; PubMed Central PMCID:
PMC8113065.
10-Year Breast Cancer Outcomes in Women ≤35 Years of Age.
Int J Radiat Oncol Biol Phys.
2021 Mar 15;109(4):1007-1018. doi: 10.1016/j.ijrobp.2020.10.022. Epub 2020 Oct 24. PubMed PMID:
33371964; PubMed Central PMCID:
PMC8006530.
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.
J Natl Cancer Inst.
2021 Mar 1;113(3):266-273. doi: 10.1093/jnci/djaa095. PubMed PMID:
32726432; PubMed Central PMCID:
PMC7936050.
Tolerability of Breast Radiotherapy Among Carriers of ATM Germline Variants.
JCO Precis Oncol.
2021;5. doi: 10.1200/PO.20.00334. eCollection 2021. PubMed PMID:
34250389; PubMed Central PMCID:
PMC8232182.
Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer.
JAMA Netw Open.
2020 Oct 1;3(10):e2018790. doi: 10.1001/jamanetworkopen.2020.18790. PubMed PMID:
33034638; PubMed Central PMCID:
PMC7547365.
Feasibility of Breast-Conservation Therapy and Hypofractionated Radiation in the Setting of Prior Breast Augmentation.
Pract Radiat Oncol.
2020 Sep-Oct;10(5):e357-e362. doi: 10.1016/j.prro.2020.01.003. Epub 2020 Mar 20. PubMed PMID:
32006728; PubMed Central PMCID:
PMC7483319.
5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial.
Int J Radiat Oncol Biol Phys.
2020 Jul 15;107(4):694-700. doi: 10.1016/j.ijrobp.2020.03.020. Epub 2020 Apr 11. PubMed PMID:
32289474; PubMed Central PMCID:
PMC7373304.
Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States.
Adv Radiat Oncol.
2020 Jul-Aug;5(4):582-588. doi: 10.1016/j.adro.2020.03.013. eCollection 2020 Jul-Aug. Review. PubMed PMID:
32292842; PubMed Central PMCID:
PMC7118660.
Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older.
Breast Cancer Res Treat.
2020 Jul;182(2):355-365. doi: 10.1007/s10549-020-05706-2. Epub 2020 May 28. PubMed PMID:
32468336.
From Orientation to Onboarding: A Survey-Based Departmental Improvement Program for New Radiation Oncology Faculty Physicians.
JCO Oncol Pract.
2020 Apr;16(4):e395-e404. doi: 10.1200/JOP.19.00641. Epub 2020 Feb 6. PubMed PMID:
32048921; PubMed Central PMCID:
PMC10435033.
Radiotherapy in the setting of hypersensitivity syndromes.
Breast J.
2020 Mar;26(3):588-589. doi: 10.1111/tbj.13621. Epub 2019 Sep 12. PubMed PMID:
31513307; PubMed Central PMCID:
PMC7604742.
Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
Breast Cancer Res Treat.
2020 Feb;180(1):197-205. doi: 10.1007/s10549-019-05520-5. Epub 2020 Jan 14. PubMed PMID:
31938938; PubMed Central PMCID:
PMC7035176.
Patterns of Recurrence Among Higher-Risk Patients Receiving Daily External Beam Accelerated Partial-Breast Irradiation to 40 Gy in 10 Fractions.
Adv Radiat Oncol.
2020 Jan-Feb;5(1):27-33. doi: 10.1016/j.adro.2019.07.017. eCollection 2020 Jan-Feb. PubMed PMID:
32051887; PubMed Central PMCID:
PMC7004933.
Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol.
BMJ Open.
2019 Oct 15;9(10):e025556. doi: 10.1136/bmjopen-2018-025556. PubMed PMID:
31619413; PubMed Central PMCID:
PMC6797426.
5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost.
Int J Radiat Oncol Biol Phys.
2019 Oct 1;105(2):267-274. doi: 10.1016/j.ijrobp.2019.05.063. Epub 2019 Jun 5. PubMed PMID:
31175905; PubMed Central PMCID:
PMC9710864.
Radiation Therapy Without Hormone Therapy for Women Age 70 or Above with Low-Risk Early Breast Cancer: A Microsimulation.
Int J Radiat Oncol Biol Phys.
2019 Oct 1;105(2):296-306. doi: 10.1016/j.ijrobp.2019.06.014. Epub 2019 Jun 15. PubMed PMID:
31212043.
Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment.
Int J Radiat Oncol Biol Phys.
2019 Jul 15;104(4):714-723. doi: 10.1016/j.ijrobp.2018.12.021. Epub 2018 Dec 14. PubMed PMID:
30557673; PubMed Central PMCID:
PMC10915745.
Daily Fractionation of External Beam Accelerated Partial Breast Irradiation to 40 Gy Is Well Tolerated and Locally Effective.
Int J Radiat Oncol Biol Phys.
2019 Jul 15;104(4):859-866. doi: 10.1016/j.ijrobp.2019.02.050. Epub 2019 Mar 7. PubMed PMID:
30851350; PubMed Central PMCID:
PMC7595753.
Overall Survival of Breast Cancer Patients With Locoregional Failures Involving Internal Mammary Nodes.
Adv Radiat Oncol.
2019 Jul-Sep;4(3):447-452. doi: 10.1016/j.adro.2019.02.004. eCollection 2019 Jul-Sep. PubMed PMID:
31360798; PubMed Central PMCID:
PMC6639740.
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial.
Int J Radiat Oncol Biol Phys.
2019 May 1;104(1):67-74. doi: 10.1016/j.ijrobp.2018.12.050. Epub 2019 Jan 4. PubMed PMID:
30611839; PubMed Central PMCID:
PMC7373303.
A Current Review of Spatial Fractionation: Back to the Future?.
Int J Radiat Oncol Biol Phys.
2019 May 1;104(1):177-187. doi: 10.1016/j.ijrobp.2019.01.073. Epub 2019 Jan 23. Review. PubMed PMID:
30684666; PubMed Central PMCID:
PMC7443362.
The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo.
Oncotarget.
2019 Apr 19;10(29):2824-2834. doi: 10.18632/oncotarget.26854. eCollection 2019 Apr 19. PubMed PMID:
31073373; PubMed Central PMCID:
PMC6497458.
A 3-Dimensional Mapping Analysis of Regional Nodal Recurrences in Breast Cancer.
Int J Radiat Oncol Biol Phys.
2019 Mar 1;103(3):583-591. doi: 10.1016/j.ijrobp.2018.10.021. Epub 2018 Oct 24. PubMed PMID:
30367906; PubMed Central PMCID:
PMC8135107.
Current Strategies for the Management of Locoregional Breast Cancer Recurrence.
Oncology (Williston Park).
2019 Jan 17;33(1):19-25. Review. PubMed PMID:
30731014.
Breast-conservation Therapy After Neoadjuvant Chemotherapy Does Not Compromise 10-Year Breast Cancer-specific Mortality.
Am J Clin Oncol.
2018 Dec;41(12):1246-1251. doi: 10.1097/COC.0000000000000456. PubMed PMID:
29782362; PubMed Central PMCID:
PMC8077450.
What would you like to do?